Skip to main content
TipRanks
Go Ultimate75% OFF

Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

0 Followers
JP:7600

Japan Medical Dynamic Marketing, Inc.

(TSE/TYO:7600)

Select Model
Rating:38Underperform
Price Target:JPY 277.00â–²(6.13% Upside)
Action:reiterated
Date:11/07/26

Japan Medical Dynamic Marketing scores near the bottom of the range, driven primarily by severe fundamental deterioration: profitability has collapsed across gross, operating and net margins, FY2025 ended in a net loss, revenue is projected to decline in FY2026, and free cash flow has turned deeply negative while debt has nearly quadrupled. Technicals compound the concern, with the share price trading well below all major moving averages and momentum indicators at extremely depressed levels. A 3.76% dividend yield and a still-solid equity ratio provide some support, but with negative earnings and negative free cash flow, dividend sustainability and a near-term turnaround remain uncertain. Investors should look for evidence that the heavy investment cycle is translating into margin and cash flow recovery before the risk profile improves.

Positive Factors
Moderate LeverageModerate leverage and a large equity base provide financial flexibility relative to a more highly indebted structure. This can help the company absorb operating volatility and preserve capacity for investment, although the recent increase in debt warrants monitoring.
Negative Factors
Revenue DeclineThe shift from strong earlier growth to a year-over-year revenue decline signals weaker recent operating momentum. If sustained, lower sales would reduce scale benefits, limit investment capacity, and make it harder for the company to rebuild profitability.

Japan Medical Dynamic Marketing, Inc. (7600) vs. iShares MSCI Japan ETF (EWJ)

-50%-25%0%25%50%75%100%125%JP:7600-43.51%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 7.06B
Dividend Yield
5.76%
Average Volume (3M)
376.84K
Price to Earnings (P/E)
-4.6
Beta (1Y)
1.06
Revenue Growth
-8.68%
EPS Growth
-75.03%
Country
Japan
Employees
539
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (JMDM) engages in the development, production, importation, and distribution of medical instruments throughout Japan and the United States. Its product portfolio features a variety of trauma devices, including su...

How the Company Makes Money

The company primarily generates revenue through the sale and distribution of medical devices and related healthcare products to customers such as hospitals, clinics, and other medical institutions. Revenue is typically recognized from product sales (...

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

Financial health has deteriorated sharply. The income statement (score 28) shows gross margins collapsing from ~68% to ~53%, EBIT margins down to 2.4%, a net loss in FY2025 and a projected -4.3% revenue decline in FY2026. Cash flow (score 25) is the weakest link: operating cash flow fell over 93% to ¥206M and free cash flow is deeply negative at -¥1.75B as capex far outstrips earnings. The balance sheet (score 52) is the relative bright spot, with a solid ~71% equity ratio and growing equity, but total debt has nearly quadrupled in two years to ¥5.9B and ROE has fallen to roughly 1%, indicating investments are being funded by borrowing rather than internal cash generation.

Income Statement

28Negative

Balance Sheet

52Neutral

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue23.32B23.92B25.11B23.18B21.31B19.19B
Gross Profit12.00B12.74B15.65B14.76B13.99B12.99B
EBITDA1.62B2.19B1.40B3.27B3.35B4.21B
Net Income-220.55M263.14M-461.80M1.27B1.42B2.14B
Balance Sheet
Total Assets35.38B35.68B33.83B31.49B29.43B27.34B
Cash, Cash Equivalents and Short-Term Investments2.56B3.11B3.18B2.32B2.80B2.59B
Total Debt6.63B5.87B3.29B1.49B1.87B1.85B
Total Liabilities10.55B10.25B9.09B5.88B6.14B5.85B
Stockholders Equity24.81B25.40B24.68B25.51B23.16B21.39B
Cash Flow
Free Cash Flow0-1.75B-504.10M302.45M870.67M1.53B
Operating Cash Flow0205.55M1.05B2.10B2.19B3.11B
Investing Cash Flow0-2.00B-1.67B-1.80B-1.48B-1.75B
Financing Cash Flow01.65B1.49B-840.71M-514.78M-1.29B

Japan Medical Dynamic Marketing, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price261.00

Price Trends

50DMA552.90Negative
100DMA711.06Negative
200DMA664.53Negative

Market Momentum

MACD-90.20Positive
RSI11.61Positive
STOCH8.04Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 261.00 is below the 20-day moving average (MA) of 427.20, below the 50-day MA of 552.90, and below the 200-day MA of 664.53, indicating a bearish trend. The MACD of -90.20 indicates Positive momentum. The RSI at 11.61 is Positive, neither overbought nor oversold. The STOCH value of 8.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7600 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.02B12.03―6.10%17.11%23.02%
JP:6849JP:684963NeutralJPY 249.68B20.61―2.10%-0.18%-33.38%
JP:6523JP:652361NeutralJPY 164.51B11.068.71%3.25%2.74%145.33%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:4549JP:454950NeutralJPY 75.00B39.80―2.55%3.92%-52.01%
JP:7779JP:777948NeutralJPY 35.89B256.250.34%―-7.45%―
JP:7600JP:760038UnderperformJPY 7.77B-4.61―5.76%-8.68%-75.03%

* Healthcare Sector Average

Performance Comparison

0%50%100%JP:7600JP:7779JP:6523JP:4549JP:6678JP:6849Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7600 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7600Japan Medical Dynamic Marketing, Inc.261.00-205.88-44.10%
JP:7779CYBERDYNE 162.00-9.00-5.26%
JP:6523PHC Holdings Corp.1236.00278.2629.05%
JP:4549Eiken Chemical Co., Ltd.2235.00-57.25-2.50%
JP:6678Techno Medica Co., Ltd.2118.00234.9812.48%
JP:6849Nihon Kohden Corporation1514.50-3.68-0.24%

Japan Medical Dynamic Marketing, Inc. Corporate Events

TSE Approves Japan Medical Dynamic Marketing’s Move to Standard Market

Nov 20, 2026

Japan Medical Dynamic Marketing, Inc. is listed on the Tokyo Stock Exchange under securities code 7600.The Tokyo Stock Exchange approved the company’s market-segment change from the Prime Market to the Standard Market on November 20, effective Novemb...

Japan Medical Dynamic Marketing Outlines First-Half Results Briefing Agenda

Nov 12, 2026

Japan Medical Dynamic Marketing, Inc. provided an agenda for its financial results briefing covering the interim period of the fiscal year ending March 2027. The agenda covers first-half consolidated sales and income, product-category sales reviews i...

Japan Medical Marketing Announces Management Cuts and Business Improvement Plan

Nov 4, 2026

Japan Medical Dynamic Marketing operates in the orthopedic medical-device industry, supplying trauma and spine products in Japan and the United States. Its market focus includes priority customers, new product adoption and recovery of procedure volum...

Japan Medical Dynamic Marketing Reports Interim Loss and Withdraws Dividend

Nov 4, 2026

Japan Medical Dynamic Marketing is a medical-device company focused on orthopedic products, including joint-replacement systems, with operations in Japan and the United States. Its business is exposed to hospital adoption trends, product competitiven...

Japan Medical Dynamic Marketing Swings to Interim Loss as Sales Decline

Nov 4, 2026

Japan Medical Dynamic Marketing, Inc. is a Tokyo-listed medical-device marketing company, although the release does not detail its product portfolio or market focus. For the six months ended September 30, 2026, consolidated sales fell 10.1% year over...

Japan Medical Dynamic Marketing Cuts U.S. Workforce to Bolster Profitability

Oct 15, 2026

Japan Medical Dynamic Marketing, Inc. has launched cost-cutting measures at its U.S. subsidiary Ortho Development Corporation, driven by declining net sales and the need to strengthen its earnings base. The subsidiary will undergo an organizational r...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026